Beta-Lactam–Cannabinoid Conjugates for Oxidative Stress Mitigation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing therapeutics often fail to deliver multiple therapeutic benefits simultaneously through distinct mechanisms of action, and antibiotics like β-lactams can induce oxidative stress leading to cell death, which may not be effectively mitigated.

Innovation Solution

Development of multifunctional conjugate molecules comprising a β-lactam antibiotic and a cannabinoid covalently attached via a linker, where the β-lactam targets its site of action, releasing the cannabinoid to provide additional therapeutic benefits, such as reducing oxidative stress and promoting apoptosis in bacteria.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If β-lactam antibiotics are used to treat bacterial infections, then antibacterial activity is improved, but oxidative stress is generated leading to harmful effects

Engineering Contradiction:
Improveantibacterial activityVSAvoidoxidative stress
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent converts the harmful oxidative stress generated by β-lactam antibiotics into a beneficial effect by coupling the antibiotic with a cannabinoid that can modulate the oxidative response. The cannabinoid component mitigates the harmful oxidative stress while the β-lactam maintains its antibacterial activity, thus transforming the harmful byproduct into a therapeutic advantage.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent creates a composite therapeutic molecule by covalently linking a β-lactam antibiotic component with a cannabinoid component through a linker. This composite structure allows the molecule to simultaneously deliver antibacterial activity from the β-lactam and oxidative stress mitigation from the cannabinoid, resolving the contradiction between efficacy and harmful side effects.

Inventive Principle:
Principle #40Composite materials

2Productivity

If traditional therapeutics are used, then single mechanism of action is provided, but multiple therapeutic benefits cannot be achieved simultaneously

Engineering Contradiction:
Improvetherapeutic benefit deliveryVSAvoidmechanism of action diversity
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

The patent designs a multifunctional conjugate molecule where a single therapeutic agent performs multiple functions: the β-lactam component provides antibacterial activity by targeting bacterial cell wall synthesis, while the cannabinoid component provides additional therapeutic benefits such as modulating oxidative stress and potentially affecting bacterial membrane integrity. This multi-functionality allows simultaneous delivery of multiple therapeutic benefits through distinct mechanisms of action.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent segments the therapeutic functions into distinct components (β-lactam antibiotic and cannabinoid) that are covalently linked but can be released separately. The β-lactam targets its site of action and releases the cannabinoid, which then provides a second therapeutic benefit. This segmentation allows each component to operate through its own mechanism of action while working together toward multiple therapeutic goals.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The conjugate molecules deliver dual therapeutic effects by enhancing the antibacterial activity of β-lactams while mitigating oxidative stress and inducing apoptosis, offering a broader spectrum of treatment benefits.

Implementation Method 1

the covalent binding of the β-lactam antibiotic component to its target enables the release of the cannabinoid

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Implementation Method 2

the formation of reactive oxygen species (ROS) is a by-product of the normal process of respiration in an oxygen-rich environment

Methodology Applied
Scientific EffectOxidative stress: Oxidation

Data Source

PatentUS20250222118A1Beta-Lactam-Cannabinoid Conjugate Molecules
Publication Date: 2025.07.10 DIVERSE BIOTECH INC
  • US20250222118A1 patent drawing
  • US20250222118A1 patent drawing
  • US20250222118A1 patent drawing

AI summary

This disclosure provides multifunctional conjugate molecules in which at least one β-lactam antibiotic is covalently attached to a cannabinoid by means of a linker. The disclosed conjugate molecules are designed to deliver therapeutic benefits as intact molecules, with release of the cannabinoid upon binding of the β-lactam antibiotic to its target conveying further therapeutic benefits, and can be used to treat bacterial infections and other disorders.